Back to directory

UCLA Amyloidosis Program

UCLA/Ronald Reagan UCLA Medical Center

AL Amyloidosis ATTRv ATTRwt AA Amyloidosis 2 Rare Subtypes

Contact Information

Primary Contact

Anasheh Halabi

Associate Clinical Professor, Director, UCLA Neuropathy Program

Activity level

  • Patients per year130
  • New diagnoses per year15

Multidisciplinary team

  • HematologyOn-site
  • CardiologyOn-site
  • NephrologyOn-site
  • NeurologyOn-site
  • PathologyOn-site
Other specialists
GeneticistsGenetic counsellorsNuclear medicine specialistsCardiac imaging specialists

Diagnostic capabilities

  • EchocardiographyOn-site
  • Cardiac MRI (CMR)On-site
  • Radionuclide imagingOn-site
  • Histopathology (Congo red)On-site
  • Amyloid typingThrough network partners
  • Genetic testingOn-site
  • Fat aspiration / labial gland biopsyOn-site
  • Organ biopsiesOn-site

Subtype expertise

  • ALYes
  • ATTRvYes
  • ATTRwtYes
  • AAYes
Rare subtypes
Localised amyloidosisGelsolin (AGel)
Referral pathways

UCLA has an Amyloid Referral mechanism whereby any patient with concern for diagnosis of Amyloidosis has direct access to the clinic.

Treatment options

  • Chemotherapy (AL)Available on-site
  • TTR stabilizersAvailable on-site
  • RNA interferenceAvailable on-site
  • Antisense oligonucleotidesAvailable on-site
  • Stem cell transplantAvailable on-site
  • Heart transplantAvailable on-site
  • Kidney transplantAvailable on-site
  • Liver transplantAvailable on-site

Patient support services

Services offered
Genetic counsellingNutritional guidance (dietitian)Specialty pharmacyFinancial or access counselling

Networks & telemedicine

  • Telemedicine / virtual consultationYes
  • Part of a formal amyloidosis networkNo
  • Diagnostic services for other organisationsNo
Diagnostic services contact
Listings are self-reported by each center and have not been independently verified by the International Society of Amyloidosis (ISA). Inclusion in this directory does not constitute certification, accreditation, or endorsement by ISA.